Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.
暂无分享,去创建一个
S H Heisterkamp | J. de Haes | R. D. de Haan | S. Heisterkamp | S. Heisterkamp | J C J M De Haes | A. de Graeff | C. Koedoot | P. Bakker | C G Koedoot | P J M Bakker | A De Graeff | R J De Haan | J. HaandeR. | M. HaesdeJ.C.J. | A. Graeffde
[1] A. Stiggelbout,et al. Choices in oncology: factors that influence patients' treatment preference , 1994, Quality of Life Research.
[2] D. Cella,et al. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Espinàs,et al. Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial , 2001, BMJ : British Medical Journal.
[4] A. Oza,et al. Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R Smith,et al. PubMed Central: creating an Aladdin's cave of ideas , 2001, BMJ : British Medical Journal.
[6] A. Zietman,et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.
[7] A. Goldhirsch,et al. Depression and degree of acceptance of adjuvant cytotoxic drugs , 2000, The Lancet.
[8] K. Kurth,et al. Quality of Life Assessment in Patients with Hormone–Resistant Prostate Cancer Treated with Epirubicin or with Epirubicin plus Medroxy Progesterone Acetate – Is It Feasible? , 2000, European Urology.
[9] J. Klijn,et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. , 2000, European journal of cancer.
[10] E. Eisenhauer,et al. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J W Peabody,et al. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. , 2000, JAMA.
[12] J. Daurès,et al. Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. , 2000, American journal of clinical oncology.
[13] E. Rutgers,et al. Interpretive Review : Feasibility and Effects of Decision Aids , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[14] D. Cella,et al. Age‐related differences in the quality of life of breast carcinoma patients after treatment , 1999, Cancer.
[15] C. Charles,et al. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. , 1999, Social science & medicine.
[16] A. Norman,et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Vos. Clinical decision making in cardiopulmonary resuscitation , 1999 .
[18] C. Alonso,et al. Small-cell lung cancer in the elderly--is age of patient a relevant factor? , 1999, Acta oncologica.
[19] I D Graham,et al. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. , 1999, Journal of the National Cancer Institute. Monographs.
[20] R. Rubens,et al. Do patients with advanced breast cancer benefit from chemotherapy? , 1998, British Journal of Cancer.
[21] H. Welch,et al. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.
[22] T. Hickish,et al. Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors. , 1998, British Journal of Cancer.
[23] I. Tannock,et al. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[24] I. Tannock. Conventional cancer therapy: promise broken or promise delayed? , 1998, The Lancet.
[25] H. Tunstall-Pedoe,et al. Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.
[26] C. Charles,et al. Doing Nothing is No Choice: Lay Constructions of Treatment Decision‐making Among Women with Early‐stage Breast Cancer , 1998 .
[27] C. Charles,et al. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). , 1997, Social science & medicine.
[28] J. Hainsworth,et al. Mitoxantrone, 5‐fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5‐fluorouracil (CMF) in first‐line chemotherapy for patients with metastatic breast carcinoma , 1997 .
[29] N. Thatcher,et al. Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine. , 1997, European journal of cancer.
[30] G. Henze. Childhood acute lymphoblastic leukaemia. , 1997, European journal of cancer.
[31] J. Wennberg. Presidential Guest Speaker: Practice Variations and the Challenge to Leadership , 1996 .
[32] J. Wennberg. Practice variations and the challenge to leadership. , 1996, Spine.
[33] M. Barry,et al. Patient Reactions to a Program Designed to Facilitate Patient Participation in Treatment Decisions for Benign Prostatic Hyperplasia , 1995, Medical care.
[34] D. Cella,et al. Someone to live for: social well-being, parenthood status, and decision-making in oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] H. Muss,et al. Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] J. D. Haes,et al. Deciding to cease active cancer treatment: issues in process and outcome , 1995 .
[37] I. Tannock,et al. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] I. Tannock,et al. Goals of palliative cancer therapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] F. Porzsolt,et al. Goals of palliative cancer therapy: scope of the problem. , 1993, Cancer treatment reviews.
[40] J. Sloan,et al. Decision making during serious illness: what role do patients really want to play? , 1992, Journal of clinical epidemiology.
[41] I. Tannock,et al. Use of a physician-directed questionnaire to define a consensus about management of breast cancer: implications for assessing costs and benefits of treatment. , 1992, Journal of the National Cancer Institute. Monographs.
[42] C. Minkovitz,et al. Oncologists vary in their willingness to undertake anti-cancer therapies. , 1991, British Journal of Cancer.
[43] H. Llewellyn-Thomas,et al. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. , 1991, Social science & medicine.
[44] S. Piantadosi,et al. Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] W. Gregory,et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.
[46] D. Tritchler,et al. Cancer Patients: Their Desire for Information and Participation in Treatment Decisions , 1989, Journal of the Royal Society of Medicine.
[47] G. Kitagawa,et al. Akaike Information Criterion Statistics , 1988 .
[48] L. Degner,et al. Life-death decisions in health care , 1987 .